These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 21049301)
21. Pharmacoproteomics of a metalloproteinase hydroxamate inhibitor in breast cancer cells: dynamics of membrane type 1 matrix metalloproteinase-mediated membrane protein shedding. Butler GS; Dean RA; Tam EM; Overall CM Mol Cell Biol; 2008 Aug; 28(15):4896-914. PubMed ID: 18505826 [TBL] [Abstract][Full Text] [Related]
22. EMMPRIN mediates beta-adrenergic receptor-stimulated matrix metalloproteinase activity in cardiac myocytes. Siwik DA; Kuster GM; Brahmbhatt JV; Zaidi Z; Malik J; Ooi H; Ghorayeb G J Mol Cell Cardiol; 2008 Jan; 44(1):210-7. PubMed ID: 17869266 [TBL] [Abstract][Full Text] [Related]
23. Matrix metalloproteinase inhibitors: a review on pharmacophore mapping and (Q)SARs results. Kontogiorgis CA; Papaioannou P; Hadjipavlou-Litina DJ Curr Med Chem; 2005; 12(3):339-55. PubMed ID: 15723623 [TBL] [Abstract][Full Text] [Related]
24. Structural basis for potent slow binding inhibition of human matrix metalloproteinase-2 (MMP-2). Rosenblum G; Meroueh SO; Kleifeld O; Brown S; Singson SP; Fridman R; Mobashery S; Sagi I J Biol Chem; 2003 Jul; 278(29):27009-15. PubMed ID: 12679334 [TBL] [Abstract][Full Text] [Related]
25. X-ray structure of a novel matrix metalloproteinase inhibitor complexed to stromelysin. Dunten P; Kammlott U; Crowther R; Levin W; Foley LH; Wang P; Palermo R Protein Sci; 2001 May; 10(5):923-6. PubMed ID: 11316871 [TBL] [Abstract][Full Text] [Related]
26. Hydrogen peroxide enhances osteopontin expression and matrix metalloproteinase activity in aortic vascular smooth muscle cells. Hu T; Luan R; Zhang H; Lau WB; Wang Q; Zhang Y; Wang HC; Tao L Clin Exp Pharmacol Physiol; 2009 Jul; 36(7):626-30. PubMed ID: 19076167 [TBL] [Abstract][Full Text] [Related]
27. Sulfonate ester hydroxamic acids as potent and selective inhibitors of TACE enzyme. Levin JI; Du MT Drug Des Discov; 2003; 18(4):123-6. PubMed ID: 15553924 [TBL] [Abstract][Full Text] [Related]
28. A bioinorganic perspective on matrix metalloproteinase inhibition. Puerta DT; Cohen SM Curr Top Med Chem; 2004; 4(15):1551-73. PubMed ID: 15579096 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of enzyme activity of and cell-mediated substrate cleavage by membrane type 1 matrix metalloproteinase by newly developed mercaptosulphide inhibitors. Hurst DR; Schwartz MA; Jin Y; Ghaffari MA; Kozarekar P; Cao J; Sang QX Biochem J; 2005 Dec; 392(Pt 3):527-36. PubMed ID: 16026329 [TBL] [Abstract][Full Text] [Related]
31. Modulation of phorbol ester-induced regulation of matrix metalloproteinases and tissue inhibitors of metalloproteinases by SB203580, a specific inhibitor of p38 mitogen-activated protein kinase. Park MJ; Park IC; Hur JH; Kim MS; Lee HC; Woo SH; Lee KH; Rhee CH; Hong SI; Lee SH J Neurosurg; 2002 Jul; 97(1):112-8. PubMed ID: 12134900 [TBL] [Abstract][Full Text] [Related]
33. Development of Thioaryl-Based Matrix Metalloproteinase-12 Inhibitors with Alternative Zinc-Binding Groups: Synthesis, Potentiometric, NMR, and Crystallographic Studies. Nuti E; Cuffaro D; Bernardini E; Camodeca C; Panelli L; Chaves S; Ciccone L; Tepshi L; Vera L; Orlandini E; Nencetti S; Stura EA; Santos MA; Dive V; Rossello A J Med Chem; 2018 May; 61(10):4421-4435. PubMed ID: 29727184 [TBL] [Abstract][Full Text] [Related]
34. Adiponectin mediates cardioprotection in oxidative stress-induced cardiac myocyte remodeling. Essick EE; Ouchi N; Wilson RM; Ohashi K; Ghobrial J; Shibata R; Pimentel DR; Sam F Am J Physiol Heart Circ Physiol; 2011 Sep; 301(3):H984-93. PubMed ID: 21666115 [TBL] [Abstract][Full Text] [Related]
35. Examination of novel zinc-binding groups for use in matrix metalloproteinase inhibitors. Puerta DT; Cohen SM Inorg Chem; 2003 Jun; 42(11):3423-30. PubMed ID: 12767177 [TBL] [Abstract][Full Text] [Related]
36. Mechanism of inhibition of matrix metalloproteinase-9 induction by NO in vascular smooth muscle cells. Gurjar MV; DeLeon J; Sharma RV; Bhalla RC J Appl Physiol (1985); 2001 Sep; 91(3):1380-6. PubMed ID: 11509539 [TBL] [Abstract][Full Text] [Related]
37. Aminoguanidine inhibits ventricular fibrosis and remodeling process in isoproterenol-induced hypertrophied rat hearts by suppressing ROS and MMPs. Parthasarathy A; Gopi V; Devi K M S; Balaji N; Vellaichamy E Life Sci; 2014 Nov; 118(1):15-26. PubMed ID: 25445437 [TBL] [Abstract][Full Text] [Related]
38. The 1.8-A crystal structure of a matrix metalloproteinase 8-barbiturate inhibitor complex reveals a previously unobserved mechanism for collagenase substrate recognition. Brandstetter H; Grams F; Glitz D; Lang A; Huber R; Bode W; Krell HW; Engh RA J Biol Chem; 2001 May; 276(20):17405-12. PubMed ID: 11278347 [TBL] [Abstract][Full Text] [Related]
39. Xanthine oxidase activates pro-matrix metalloproteinase-2 in cultured rat vascular smooth muscle cells through non-free radical mechanisms. Liu W; Rosenberg GA; Shi H; Furuichi T; Timmins GS; Cunningham LA; Liu KJ Arch Biochem Biophys; 2004 Jun; 426(1):11-7. PubMed ID: 15130778 [TBL] [Abstract][Full Text] [Related]
40. Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity. Rouanet-Mehouas C; Czarny B; Beau F; Cassar-Lajeunesse E; Stura EA; Dive V; Devel L J Med Chem; 2017 Jan; 60(1):403-414. PubMed ID: 27996256 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]